Elutia Inc.
$1.12
▲
7.34%
2026-04-21 06:37:00
elutia.com
NCM: ELUT
Explore Elutia Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$49.2 M
Current Price
$1.12
52W High / Low
$2.64 / $0.5
Stock P/E
0.92
Book Value
$0.65
Dividend Yield
—
ROCE
-49.48%
ROE
-574.35%
Face Value
—
EPS
$-0.64
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
25
Beta
0.71
Debt / Equity
14.24
Current Ratio
2.22
Quick Ratio
2.12
Forward P/E
-1.03
Price / Sales
3.93
Enterprise Value
$15.94 M
EV / EBITDA
-0.93
EV / Revenue
1.3
Rating
None
Target Price
$5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | MaxCyte, Inc. | $0.86 | — | $91.86 M | — | -24.06% | -23.63% | $2.96 / $0.64 | $1.61 |
| 2. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
| 3. | Bruker Corporation | $41.1 | — | $6.23 B | 0.49% | 4.76% | -0.38% | $56.22 / $28.53 | $16.15 |
| 4. | Orthofix Medical Inc. | $12.65 | — | $507.83 M | — | -12.14% | -19.34% | $16.99 / $10.24 | $11.3 |
| 5. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 6. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
| 7. | Axogen, Inc. | $37.23 | — | $2 B | — | -3.96% | -13.49% | $39.99 / $9.22 | $2.73 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 3.27 M | 3.32 M | 6.26 M | 6.03 M | 5.47 M | — |
| Operating Profit | -5.49 M | -4.36 M | -5.87 M | -5.35 M | -5.82 M | — |
| Net Profit | 70.79 M | -3.87 M | -9.61 M | -3.93 M | -9.06 M | — |
| EPS in Rs | 1.65 | -0.09 | -0.22 | -0.09 | -0.21 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 12.29 M | 14.47 M | 24.75 M | 23.85 M |
| Operating Profit | -18.41 M | -19.34 M | -20.54 M | -29.99 M |
| Net Profit | 53.38 M | -53.95 M | -37.66 M | -32.9 M |
| EPS in Rs | 1.25 | -1.26 | -0.88 | -0.77 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 62.35 M | 36.13 M | 43.43 M | 68.84 M |
| Total Liabilities | 34.68 M | 82.39 M | 82.03 M | 73.87 M |
| Equity | 27.67 M | -46.26 M | -38.6 M | -5.03 M |
| Current Assets | 55.82 M | 26.17 M | 31.25 M | 50.7 M |
| Current Liabilities | 25.14 M | 37.8 M | 43.04 M | 42.62 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -44.81 M | -22.66 M | -21.76 M | -21.43 M |
| Investing CF | 78.56 M | -0.47 M | 14.21 M | -0.54 M |
| Financing CF | -10.64 M | 17.09 M | 9.84 M | 8.54 M |
| Free CF | -46.69 M | -23.31 M | -22.11 M | -21.97 M |
| Capex | -1.88 M | -0.65 M | -0.35 M | -0.54 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -41.54% | 3.76% | — | — |
| Earnings Growth % | -43.27% | -14.47% | — | — |
| Profit Margin % | -372.91% | -152.18% | -137.94% | — |
| Operating Margin % | -133.71% | -82.99% | -125.75% | — |
| Gross Margin % | 46.42% | 44.67% | 48.8% | — |
| EBITDA Margin % | -283.31% | -128.01% | -114.46% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.